Special Article: Consensus Recommendations
ZIEDONIS, DOUGLAS M. MD, MPH; SMELSON, DAVID PsyD; ROSENTHAL, RICHARD N. MD; BATKI, STEVEN L. MD; GREEN, ALAN I. MD; HENRY, RENATA J. MEd; MONTOYA, IVAN MD; PARKS, JOSEPH MD; WEISS, ROGER D. MD
ZIEDONIS and SMELSON: University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School; ROSENTHAL: Columbia University College of Physicians & Surgeons and St. Luke's Roosevelt Hospital Center, New York; BATKI: VA Center for Integrated Healthcare and SUNY Upstate Medical University; GREEN: Dartmouth Medical School; HENRY: Delaware Department of Health & Social Services; MONTOYA: National Institute of Drug Abuse; PARKS: Missouri Department of Mental Health; WEISS: McLean Hospital, Harvard Medical School.
Please send correspondence and reprint requests to: Douglas M. Ziedonis, MD, MPH, Robert Wood Johnson Medical School, 675 Hoes Lane, Room D-349, Piscataway, NJ 08854.
This article is based upon the proceedings of a consensus meeting "Improving the Management of Care for Individuals with Severe Mental Illness and Co-occurring Substance Use Disorders," held March 4-5, 2004, in Philadelphia, PA. The meeting and subsequent manuscript development were supported by unrestricted educational grants from Eli Lilly and Co. and AstraZeneca. Dr. Weiss' work was supported by Grant K02 DA00326 from the National Institute on Drug Abuse.